Apoptosis-resistant NS/0 E1B-19K myelomas exhibit increased viability and chimeric antibody productivity under cell cycle modulating conditions

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1023/A:1008054403470
AuthorSearch for: 1; Search for: 1
  1. National Research Council of Canada. NRC Biotechnology Research Institute
FormatText, Article
Subjectapoptosis; cell cycle; E1B-19K; hydroxyurea; hyperosmosis; hypertonic; monoclonal antibodies; OptiMAbTM; thymidine
Publication date
NRC number41439
NPARC number3538945
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierfb46bf38-6308-4892-a867-bd065d7b0df8
Record created2009-03-01
Record modified2020-03-20
Date modified: